Moderna Stock Price: Quote, Drivers & How to Track
Moderna stock price (Moderna, Inc. — MRNA)
moderna stock price refers to the market quote for Moderna, Inc. common shares (ticker MRNA) listed on the NASDAQ. This entry explains what that price represents, where price data is reported, which metrics matter to investors, and practical ways to track and verify up‑to‑date quotes. The guide is intended for beginners and intermediate readers wanting reliable, source‑based context without investment advice.
Company and ticker summary
Moderna, Inc. (ticker MRNA) is a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines. The moderna stock price reflects investor expectations about Moderna's current revenue, future pipeline prospects (including vaccines and therapeutics), clinical trial results, regulatory approvals, partnerships, and wider market sentiment. MRNA trades on the NASDAQ exchange during U.S. market hours and in extended trading sessions before and after the regular session.
Where the stock price is reported
The moderna stock price is available from multiple data sources and platforms: exchange consolidated feeds, company investor relations, financial news sites, and brokerage platforms. Common public quote locations include:
- Official Moderna Investor Relations stock page (IR) for company‑provided updates and IR disclosures.
- Financial news sites and market data providers for consolidated quotes and commentary (examples: CNBC, Yahoo Finance, MarketWatch — these provide quoted values and context without guaranteed realtime access).
- Retail brokerage platforms and trading apps where users place orders and view account prices (some platforms show real‑time prices to customers, others use delayed public feeds).
Note: many free consumer sites display delayed quotes (commonly 15–20 minutes delayed) unless a real‑time subscription or broker feed is provided. If you need live orderable quotes, use a broker platform that supplies real‑time NASDAQ data or a subscription data service.
When seeking the latest moderna stock price, confirm the quote timestamp and whether it represents regular hours, pre‑market, after‑hours, or consolidated tape real‑time data.
Real‑time and extended trading quotes
Regular trading hours
NASDAQ regular trading hours run from 9:30 a.m. to 4:00 p.m. Eastern Time. Most publicly reported prices for the moderna stock price reflect trades executed during this session. Common quote fields tied to regular hours include last trade price, change from prior close, percent change, and daily volume.
Pre‑market and after‑hours trading
Extended trading occurs outside regular hours in pre‑market and after‑hours sessions. After‑hours trades can move the moderna stock price significantly on news releases issued after the close. Extended session volumes are generally lower and spreads (bid/ask) wider, so prices in these sessions can be more volatile and less representative of normal liquidity. Many market pages mark these as “pre‑market” or “after‑hours”; confirm the session label and timestamp when comparing quotes.
Key market data and metrics
Investors use a standard set of data fields to interpret the moderna stock price and the underlying equity. Common metrics available on public pages include:
- Last trade price and timestamp (shows the most recent executed trade and when it occurred).
- Change and percent change (difference from previous day’s official close).
- Bid and ask (current best displayed buy and sell prices; useful for short‑term trading).
- Volume and average volume (shares traded during the session and typical daily liquidity).
- Market capitalization (market cap = share price × shares outstanding; snapshot measure of company size).
- Shares outstanding and float (total issued shares versus shares available to public investors).
- 52‑week high and low (range of trading prices over the past 52 weeks; used for relative performance).
- Beta (a measure of historical volatility versus the broader market).
- EPS (earnings per share) trailing and forward; P/E ratio when applicable (if EPS is negative, P/E may be NA).
- Short interest and percent of float (shows how much of the free float is sold short; can indicate speculative interest and potential squeeze risk).
These fields are typically visible on consolidated quote pages such as Yahoo Finance, MarketWatch, and CNBC. When using any metric, check the date/time and the data provider’s note about methodology.
Historical price performance
Historical data helps contextualize the moderna stock price over different horizons:
- Intraday charts (minute, hourly) for short‑term trading.
- Daily candlesticks for swing timeframes.
- Weekly/monthly charts for long‑term investors.
- Total return charts (price plus dividends, if any) to include distributions.
Key milestones often highlighted in historical summaries include all‑time highs, major drawdowns, and periods of concentrated news flow (earnings, trial readouts, regulatory actions). Data providers expose adjustable historical ranges (1D, 5D, 6M, 1Y, 5Y, Max). Use these tools to compute percent gains/losses over chosen intervals.
Major drivers of Moderna’s stock price
Moderna is a biotech with product and pipeline focus; the moderna stock price is especially sensitive to the following categories of news and data.
Commercial performance and revenues
Product sales, contract wins, government procurement agreements, and recurring revenue streams materially affect outlook. For Moderna, vaccine sales (historic COVID‑19 vaccines) and potential future vaccine revenues (e.g., RSV or influenza) can swing revenue forecasts and investor expectations for the moderna stock price.
Clinical trial and pipeline news
Clinical readouts, Phase transitions (Phase 1 → 2 → 3), and trial endpoints can cause large intraday moves in the moderna stock price. Positive efficacy or safety signals typically lift sentiment; setbacks or delays can depress valuation quickly. Trial collaborations (e.g., with other pharmaceutical companies) also change perceived de‑risking.
Regulatory decisions and safety communications
Approvals, Emergency Use Authorizations, label changes, safety alerts, and regulatory guidance from agencies like the FDA and EMA are high‑impact drivers. Any issued guidance or safety update that affects market access or labeling can rapidly alter the moderna stock price.
Partnerships, licensing and funding agreements
Collaborations, licensing deals, milestone payments, or government contracts can add revenue visibility and reduce development risk, often supporting a higher moderna stock price when material and credible.
Macro and sector sentiment
Biotech equities often trade with higher sensitivity to macro factors and investor risk appetite. Interest rate moves, sector rotations (into or out of growth/biotech), and broader equity market momentum influence the moderna stock price. For example, lower long‑term yields or stronger risk appetite can lift growth‑oriented equities, while rising rates may compress valuations.
Analyst coverage, ratings and price targets
Sell‑side and independent analysts publish Buy/Hold/Sell ratings and price targets that feed into investor expectations for the moderna stock price. Aggregators display consensus ratings and target medians; be mindful that analyst views update frequently after earnings, trial readouts, or material news. Ratings and targets are opinion‑based and should be considered as part of a broader set of signals rather than definitive predictors.
Trading characteristics and liquidity
Moderna typically has a high average daily volume relative to many small biotechs, improving trade execution and option market liquidity. Option volume, open interest, and implied volatility can provide additional insight into how market participants hedge or speculate on the moderna stock price. Short interest as a percent of float may indicate anticipation of negative moves or hedging demand; interpret in context with overall market positioning.
Notable historical events affecting price
Major public events that historically influence the moderna stock price include:
- Major vaccine approvals or emergency authorizations.
- High‑visibility clinical trial readouts (positive or negative) especially for lead programs.
- Large government procurement contracts or deliveries of vaccine doses.
- Material collaboration announcements with large pharmaceutical partners.
- Quarterly earnings that surprise materially above or below consensus estimates.
When chronicling these events, always supply a date and source for verification. The moderna stock price often gaps at the open following after‑hours announcements or scheduled news releases.
How to track and verify current price
Practical steps to monitor and verify the moderna stock price:
- Use the company’s Investor Relations page for official filings and IR‑stated metrics. IR is authoritative for corporate disclosures.
- Check major market data pages (CNBC, Yahoo Finance, MarketWatch) for consolidated quotes and context. Confirm whether the quote is delayed or real‑time.
- For tradeable, real‑time prices and order execution, use a brokerage platform that displays live NASDAQ quotes. When choosing where to trade or monitor equities and related derivatives, consider a trusted platform such as Bitget for integrated market data and trading tools; for custody or tokenized asset storage, Bitget Wallet is recommended for users of Bitget’s ecosystem.
- Pay attention to the quote’s timestamp and session label (regular vs extended hours).
- Cross‑verify major price moves with reputable news sources and official filings to separate rumor from confirmed disclosures.
Valuation and investment metrics
Common valuation metrics used when examining the moderna stock price include:
- Market capitalization: instantaneous measure based on the current share price.
- Price‑to‑earnings (P/E): meaningful when Moderna reports positive EPS; otherwise the ratio may be NA or not meaningful for firms investing heavily in R&D.
- Enterprise value (EV) and EV/Revenue when earnings are negative or inconsistent.
- Revenue growth, gross margins, and operating cash flow for operational context.
- Forward estimates and analyst models to compare market price versus projected fundamentals.
Valuation in biotech often requires scenario‑based modeling of pipeline probabilities, peak sales assumptions, and discount rates. When interpreting valuation relative to the moderna stock price, cite the assumptions used and avoid definitive claims.
Risks and considerations
Principal risks that can affect the moderna stock price include:
- Clinical and regulatory risk: trial failures or regulatory delays can sharply lower the price.
- Revenue concentration: reliance on a small set of products can create volatility if demand shifts or competition emerges.
- Litigation and intellectual property disputes.
- Financing and cash runway: the need to raise capital can dilute existing shareholders and pressure the price.
- Competitive risk from other developers and technology platforms.
- Market and volatility risk typical for biotechnology and growth stocks.
All risk descriptions are factual observations about typical sources of price movement and do not constitute investment advice.
Example data snapshot (date‑stamped)
As of January 23, 2026, according to Benzinga, U.S. markets were trading higher and Moderna Inc. (MRNA) experienced a significant session lift following a clinical update. A dated snapshot from that session (for illustrative verification) reads approximately as follows:
- Date and source: As of January 23, 2026, Benzinga reported market moves including Moderna.
- Reported price movement: Moderna shares rose in the session, with intraday gains reported in the 4%–6% range on published market pages.
- Context: The move followed Moderna’s announcement of updated median five‑year follow‑up data from a Phase 2b study involving an individualized neoantigen therapy in collaboration with a pharmaceutical partner.
Note: The above snapshot is date‑stamped to the cited report. For live trading or research, consult a real‑time data provider or your brokerage account and verify the timestamp and session label. Do not rely on stale snapshots for trade decisions.
See also
- Moderna, Inc. (company overview and investor relations)
- mRNA therapeutics and vaccines (technology overview)
- Biotech sector indices and ETFs (for sector comparisons)
- Peer company ticker pages and regulatory filings
References
Sources used for data, quote conventions, and market context in this entry include public market data providers and reputable financial news outlets. Key references for the moderna stock price and related market reporting are:
- Moderna Investor Relations — official stock info and company disclosures
- CNBC — market quote pages and news coverage for MRNA
- Yahoo Finance — consolidated quote and fundamentals for MRNA
- MarketWatch — quote pages and historical data for MRNA
- Robinhood — retail quote snapshots and news feed (useful for orderable quotes for some users)
- Benzinga market report dated January 23, 2026 (market session coverage mentioning Moderna’s session gains and trial update)
(When checking exact numeric values, consult the named source and confirm the quote timestamp.)
External links
For immediate price checks and live market tools, consult the following live sources and platforms (search by name in your browser or within your brokerage app):
- Moderna Investor Relations — stock page
- CNBC — MRNA quote page
- Yahoo Finance — MRNA quote
- MarketWatch — MRNA quote
- Bitget — trading platform and market data
If you want a centralized place to monitor equities and related market data while accessing trading tools, consider exploring Bitget’s market pages and Bitget Wallet for secure custody of digital assets tied to your account ecosystem. Always verify quote timestamps and session types before making decisions.
Reporting date: As of January 23, 2026, market coverage referenced above was reported by Benzinga and other financial outlets. All figures and events are time‑sensitive; verify with live sources before acting. This article is for informational purposes only and does not provide investment advice.
